The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study

BACKGROUND: Icotinib is a small molecule targeting epidermal growth factor receptor tyrosine kinase, which shows non-inferior efficacy and better safety comparing to gefitinib in previous phase III trial. The present study was designed to further evaluate the efficacy and safety of icotinib in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xingsheng, Zhang, Li, Shi, Yuankai, Zhou, Caicun, Liu, Xiaoqing, Wang, Dong, Song, Yong, Li, Qiang, Feng, Jifeng, Qin, Shukui, Xv, Nong, Zhou, Jianying, Hu, Chunhong, Zhang, Shucai, Luo, Rongcheng, Wang, Jie, Tan, Fenlai, Wang, Yinxiang, Ding, Lieming, Sun, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657981/
https://www.ncbi.nlm.nih.gov/pubmed/26599904
http://dx.doi.org/10.1371/journal.pone.0142500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657981/
https://www.ncbi.nlm.nih.gov/pubmed/26599904
http://dx.doi.org/10.1371/journal.pone.0142500

Ejemplares similares